GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioDelivery Sciences International Inc (FRA:BD5) » Definitions » Cyclically Adjusted PS Ratio

BioDelivery Sciences International (FRA:BD5) Cyclically Adjusted PS Ratio : (As of May. 27, 2024)


View and export this data going back to 2004. Start your Free Trial

What is BioDelivery Sciences International Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


BioDelivery Sciences International Cyclically Adjusted PS Ratio Historical Data

The historical data trend for BioDelivery Sciences International's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioDelivery Sciences International Cyclically Adjusted PS Ratio Chart

BioDelivery Sciences International Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BioDelivery Sciences International Quarterly Data
Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BioDelivery Sciences International's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, BioDelivery Sciences International's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioDelivery Sciences International's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioDelivery Sciences International's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where BioDelivery Sciences International's Cyclically Adjusted PS Ratio falls into.



BioDelivery Sciences International Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

BioDelivery Sciences International's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2021 is calculated as:

For example, BioDelivery Sciences International's adjusted Revenue per Share data for the three months ended in Dec. 2021 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2021 (Change)*Current CPI (Dec. 2021)
=0.372/117.6295*117.6295
=0.372

Current CPI (Dec. 2021) = 117.6295.

BioDelivery Sciences International Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201203 0.423 96.783 0.514
201206 0.417 96.819 0.507
201209 0.048 97.633 0.058
201212 0.452 96.871 0.549
201303 0.033 98.209 0.040
201306 0.055 98.518 0.066
201309 0.059 98.790 0.070
201312 0.076 98.326 0.091
201403 0.338 99.695 0.399
201406 0.211 100.560 0.247
201409 0.029 100.428 0.034
201412 0.040 99.070 0.047
201503 0.232 99.621 0.274
201506 0.029 100.684 0.034
201509 0.021 100.392 0.025
201512 0.561 99.792 0.661
201603 0.052 100.470 0.061
201606 0.083 101.688 0.096
201609 0.059 101.861 0.068
201612 0.069 101.863 0.080
201703 0.497 102.862 0.568
201706 0.140 103.349 0.159
201709 0.170 104.136 0.192
201712 0.186 104.011 0.210
201803 0.158 105.290 0.177
201806 0.175 106.317 0.194
201809 0.187 106.507 0.207
201812 0.224 105.998 0.249
201903 0.245 107.251 0.269
201906 0.313 108.070 0.341
201909 0.262 108.329 0.284
201912 0.323 108.420 0.350
202003 0.324 108.902 0.350
202006 0.300 108.767 0.324
202009 0.317 109.815 0.340
202012 0.328 109.897 0.351
202103 0.327 111.754 0.344
202106 0.336 114.631 0.345
202109 0.341 115.734 0.347
202112 0.372 117.630 0.372

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BioDelivery Sciences International  (FRA:BD5) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


BioDelivery Sciences International Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of BioDelivery Sciences International's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BioDelivery Sciences International (FRA:BD5) Business Description

Traded in Other Exchanges
N/A
Address
4131 ParkLake Avenue, Suite 225, Raleigh, NC, USA, 27612
BioDelivery Sciences International Inc is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. The company is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of therapies aimed at addressing important unmet medical needs. Its products include Belbuca and Symproic.

BioDelivery Sciences International (FRA:BD5) Headlines

No Headlines